Guest Host: Steve Roberts

Vioxx, antidepressants, and a new FDA drug safety board are all on the agenda as Steve Roberts leads a discussion about the Food and Drug Administration and how well it is protecting consumers.

Guests

  • Dr. Jerry Avorn author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston
  • Marc Kaufman reporter on the national desk of "The Washington Post"
  • Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

The Future Of The United Nations

Thursday, Mar 26 2015The United Nations has recently come under attack for its handling of both the Ebola outbreak and the war in Syria. It has prompted some to question what the role of the U.N. should be on the international stage. We look at the relevance of the U.N., 70 years after its creation.

The Future Of U.S. Military Presence in Afghanistan

Wednesday, Mar 25 2015Nearly 10,000 U.S. military personnel remain in Afghanistan after combat forces withdrew last year. We explore a meeting between U.S. and Afghan officials this week, prospects for Congressional approval of additional troops and the future of security in the region.